Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, November 21, 2016 ) " Dry (Atrophic) Macular Degeneration-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Dry (Atrophic) Macular Degeneration. The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight's Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Dry (Atrophic) Macular Degeneration. DelveInsight's Report also assesses the Dry (Atrophic) Macular Degeneration therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration. . For more information http://www.reportsweb.com/dry-atrophic-macular-degeneration-pipeline-insights-2016
Table of Contents
- Dry (Atrophic) Macular Degeneration Overview - Dry (Atrophic) Macular Degeneration Pipeline Therapeutics - Dry (Atrophic) Macular Degeneration Therapeutics under Development by Companies - Dry (Atrophic) Macular Degeneration Filed and Phase III Products - Comparative Analysis - Dry (Atrophic) Macular Degeneration Phase II Products - Comparative Analysis - Dry (Atrophic) Macular Degeneration Phase I and IND Filed Products - Comparative Analysis - Dry (Atrophic) Macular Degeneration Discovery and Pre-Clinical Stage Products - Comparative Analysis - Drug Candidate Profiles - Dry (Atrophic) Macular Degeneration - Therapeutics Assessment - Assessment by Monotherapy Products - Assessment by Combination Products - Assessment by Route of Administration - Assessment by Molecule Type - Dry (Atrophic) Macular Degeneration - Discontinued Products - Dry (Atrophic) Macular Degeneration - Dormant Products - Companies Involved in Therapeutics Development for Dry (Atrophic) Macular Degeneration - Appendix - Methodology - Contact Us - Disclaimer
Request Sample Copy http://www.reportsweb.com/inquiry&RW000183099/sample
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
Source: EmailWire.com
|
|
|
|